0001356576-20-000035.txt : 20200527 0001356576-20-000035.hdr.sgml : 20200527 20200527163313 ACCESSION NUMBER: 0001356576-20-000035 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20200527 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200527 DATE AS OF CHANGE: 20200527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 20915615 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 8-K 1 supn-20200527.htm 8-K supn-20200527
false000135657600013565762020-05-272020-05-27


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 27, 2020
 
Supernus Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)

Delaware
001-3551820-2590184
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
9715 Key West Ave
Rockville
MD
20850
(Address of Principal Executive Offices)
(Zip Code)

 
Registrant’s telephone number, including area code: (301) 838-2500
 
Not Applicable
(Former name or former address, if changed since last report.)

  Securities registered pursuant to Section 12(b) of the Exchange Act
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $0.001 par value per shareSUPNThe Nasdaq Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 8.01                                           Other Events.

On May 27, 2020, Supernus Pharmaceuticals, Inc. (the “Company”) issued a press release announcing that the Company’s management will present a Company overview and update, as well as host investor meetings, at the Jefferies Virtual Healthcare Conference on June 2, 2020. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01                                          Financial Statements and Exhibits.
 
(d)                                Exhibits

 
Exhibit 99.1 — Press Release Dated May 27, 2020, furnished as an Exhibit pursuant to Item 8.01 hereof.

Exhibit 104 — The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.


2

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

 SUPERNUS PHARMACEUTICALS, INC.
  
DATED: May 27, 2020By:/s/ Gregory S. Patrick
  Gregory S. Patrick
  Senior Vice-President and Chief Financial Officer

3
 EX-99.1 2 ex99105-27x2020.htm EX-99.1 Document

              Exhibit 99.1
logoa051.jpg      
 

Supernus to Present at the Jefferies Virtual Health Care Conference

ROCKVILLE, Md., May 27, 2020 - Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company's management will present an overview and update, as well as host investor meetings, at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 4:00 p.m. ET.

Investors interested in arranging a virtual meeting with the Company's management during this conference should contact the conference coordinator.

A live webcast of the presentation can be accessed by visiting Events & Presentations in the Investor Relations section on the Company's website at www.supernus.com. An archived replay of this webcast will be available for 60 days on the Company's website after the conference.

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company currently markets Trokendi XR® (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy, and Oxtellar XR® (extended-release oxcarbazepine) for the treatment of epilepsy. The Company is also developing several product candidates to address large market opportunities in the CNS market, including SPN-812 for the treatment of ADHD, SPN-820 (NV-5138) for treatment-resistant depression, and SPN-817 for the treatment of epilepsy.

CONTACTS:
Jack A. Khattar, President and CEO
Gregory S. Patrick, Senior Vice President and CFO
Supernus Pharmaceuticals, Inc.
Tel: (301) 838-2591

or

INVESTOR CONTACT:
Peter Vozzo
Westwicke, an ICR Company
Office: (443) 213-0505
Mobile: (443) 377-4767
Email: peter.vozzo@westwicke.com

 EX-101.SCH 3 supn-20200527.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 supn-20200527_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 supn-20200527_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 supn-20200527_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name City Area Code City Area Code Cover [Abstract] Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Filer Name Entity File Number Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Trading Symbol Trading Symbol Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 7 supn-20200527_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 logoa051.jpg begin 644 logoa051.jpg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�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end XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.supernus.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports supn-20200527.htm ex99105-27x2020.htm supn-20200527.xsd supn-20200527_cal.xml supn-20200527_def.xml supn-20200527_lab.xml supn-20200527_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "supn-20200527.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "supn-20200527_cal.xml" ] }, "definitionLink": { "local": [ "supn-20200527_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "supn-20200527.htm" ] }, "labelLink": { "local": [ "supn-20200527_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "supn-20200527_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "supn-20200527.xsd" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "supn", "nsuri": "http://www.supernus.com/20200527", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "supn-20200527.htm", "contextRef": "i201ebd1ca99042068be87f94b815841a_D20200527-20200527", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.supernus.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "supn-20200527.htm", "contextRef": "i201ebd1ca99042068be87f94b815841a_D20200527-20200527", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity Filer Name" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 12 0001356576-20-000035-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001356576-20-000035-xbrl.zip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inancial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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htm IDEA: XBRL DOCUMENT v3.20.1
Cover Page
May 27, 2020
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 27, 2020
Entity Registrant Name Supernus Pharmaceuticals, Inc.
Entity Incorporation, State or Country Code DE
Entity Filer Name 001-35518
Entity Tax Identification Number 20-2590184
Entity Address, Address Line One 9715 Key West Ave
Entity Address, City or Town Rockville
Entity Address, State or Province MD
Entity Address, Postal Zip Code 20850
City Area Code 301
Local Phone Number 838-2500
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol SUPN
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001356576
XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 17 supn-20200527_htm.xml IDEA: XBRL DOCUMENT 0001356576 2020-05-27 2020-05-27 false 0001356576 8-K 2020-05-27 Supernus Pharmaceuticals, Inc. DE 001-35518 20-2590184 9715 Key West Ave Rockville MD 20850 301 838-2500 Common Stock, $0.001 par value per share SUPN NASDAQ false false false false false